Γ

SynBioBeta Speaker

Divya Chander

Lucidify

CEO, Founder

Divya Chander, MD, PhD is a physician-scientist, entrepreneur, neuroscientist, neuroethicist, and futurist. She is a practicing anesthesiologist and Founder and CEO of Lucidify, a brain-computer interface and neurotechnology platform focused on brain health, cognitive longevity, and disorders of consciousness, including delirium and sleep disruption. She served on the Stanford faculty for eight years, specializing in neuroanesthesia, and formerly chaired the Neuroscience track at Singularity University, where she now serves as a Medicine and Biotechnology Expert. As a Stimson Center Loomis Innovation Council Fellow and former Atlantic Council GeoTech Center Senior Fellow, she advises governments and industry on biometric data rights, data trusts, cybersecurity, and public health policy. She serves as advisor and board member to a number of companies.



Dr. Chander’s work centers on brain-computer interfaces, neural signal processing, and the science of consciousness. She develops technologies to decode and modulate brain function, explores cognitive enhancement and human augmentation, and investigates how understanding consciousness may inform intelligent non-human systems. A finalist for astronaut selection and alumna of the International Space University, she is also developing critical care systems and brain-computer interfaces to support astronaut health and long-duration space exploration.

Sessions Featuring

Divya

This Year

Femtech

4:30 PM

-

5:15 PM

Human Health

What Future Can We Imagine?

The brain was never static. We just lacked the language to describe its motion. That language now exists. Neuroplasticity is no longer a metaphor for resilience — it is a measurable, targetable biological phenomenon. Metabolic psychiatry is revealing that mental illness is not purely a disorder of neurotransmitters, but of energy, inflammation, and cellular environment. Cognitive engineering is moving from speculative to clinical, from enhancement to intervention, from philosophy to protocol.

Femtech

4:30 PM

-

5:15 PM

Human Health

What Future Can We Imagine?

The brain was never static. We just lacked the language to describe its motion. That language now exists. Neuroplasticity is no longer a metaphor for resilience — it is a measurable, targetable biological phenomenon. Metabolic psychiatry is revealing that mental illness is not purely a disorder of neurotransmitters, but of energy, inflammation, and cellular environment. Cognitive engineering is moving from speculative to clinical, from enhancement to intervention, from philosophy to protocol.

TBD

Session lineup still growing

Featuring

Speaker Coming Soon

Fireside Chat

12:00 AM

-

8:30 AM

Human Health

From Cells to Patients: Solving the Scale Mismatch in Virtual Biology

Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?

Featuring

Speaker Coming Soon

Previous Speakers Include